Navigating Your Mounjaro Journey: What MG Should I Take?

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide therapy starts at a low dose and advances over weeks as your body adapts, a strategy proven to reduce side effects while maximizing weight loss. Many patients worry that higher doses mean higher costs—but PlexusDx breaks that cycle. Your dose may need to go up. Your price won't.

How Tirzepatide Dosing Works in Real Practice

Tirzepatide injections follow a step-wise titration schedule that mirrors how your body tolerates the medication. Most patients begin at 2.5 milligrams once weekly, the lowest available starting dose. After four weeks, if you tolerate the initial dose well, your prescribing clinician typically increases to 5 milligrams. This gradual approach allows your appetite-regulating hormones to adjust without overwhelming nausea or gastrointestinal upset. The standard titration ladder progresses from 2.5 mg to 5 mg to 7.5 mg to 10 mg to 12.5 mg to 15 mg, with each step spaced about four weeks apart.

Your clinician determines whether you need to move to the next dose level based on your individual response—how much weight you've lost, how well you tolerate the injection, and whether you've hit a plateau. Some patients reach their therapeutic goal at 5 milligrams, while others benefit from climbing to 10 or 15 milligrams. This personalization is the entire point of precision medicine. PlexusDx serves all 50 states and works without insurance, so your treatment adjustments never trigger billing surprises. You stay on one flat monthly price as your dose climbs.

Starting Dose: Why 2.5 mg Is Standard

The 2.5 milligram starting dose was chosen based on decades of diabetes trials and Phase 3 obesity research. Beginning here allows your gastrointestinal system, appetite center, and glucose metabolism to acclimate together. Starting too high risks nausea, vomiting, constipation, and low blood sugar (if you take diabetes medication), all of which can force patients to stop treatment before they experience benefits. The lowest effective dose also gives your body time to signal true satiety—the feeling of fullness—rather than chemical suppression, which supports sustainable habit change.

PlexusDx-partnered clinicians review your medical history, current medications, and kidney function before suggesting your actual starting point. If you have severe kidney disease or take insulin, your clinician may adjust the starting approach. For most patients without contraindications, 2.5 milligrams represents the safest entry, and your flat-rate pricing begins here. You are never charged more because your dose advances over the following months.

Advancing Your Dose: Timing and Signs You're Ready

Advancing to the next tirzepatide dose typically occurs every four weeks if you tolerate your current level. Your clinician looks for three signals: one, you report that nausea or other side effects have settled to mild or absent; two, your appetite suppression has plateaued—meaning you're eating normally (but less) without constantly fighting hunger; and three, your weight loss has slowed, suggesting your body has adapted. If you skip a dose increase when ready, you risk stalling your progress. If you increase too early, you may trigger breakthrough nausea.

Some patients climb the full titration schedule from 2.5 to 15 milligrams over four to five months. Others plateau at 7.5 or 10 milligrams and maintain excellent results there indefinitely. A smaller group finds their sweet spot at 12.5 milligrams. This variation reflects real differences in your GLP-1 receptor sensitivity, your baseline metabolism, and your personal weight loss goals. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides linked to your response, helping your clinician forecast whether you'll likely benefit from lower, moderate, or higher doses before you start.

Maximum Dose and When to Stabilize

The maximum approved tirzepatide dose is 15 milligrams weekly. Doses above this have not been studied for long-term safety in obesity, so responsible clinicians do not exceed this ceiling. However, reaching 15 milligrams does not mean it is your best dose. Many patients achieve durable weight loss and feel their absolute best at 10 or 12.5 milligrams, where side effects are minimal and adherence is easier. Your clinician will recommend staying at the lowest dose that gives you meaningful results—this is evidence-based practice.

Once you land on your maintenance dose, you typically remain there indefinitely. Some patients maintain their weight loss on the same dose for years. Others, especially those who have lost significant weight, may eventually drop back to a lower dose to manage side effects or cost of related medications. PlexusDx supports this flexibility. Since your price stays flat month to month, you never pay more for dose adjustments up or down, and your clinician can titrate based purely on what works for your body, not your budget.

The PlexusDx Advantage: Flat Pricing Across All Doses

Traditional weight loss clinics charge by dose or by the number of pens dispensed, so patients face mounting costs as they advance their tirzepatide from 2.5 to 15 milligrams. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), flat, whether you inject 2.5 milligrams or 15 milligrams weekly. Your dose may need to go up. Your price won't. This model removes a major psychological and financial barrier to treatment optimization. You are never incentivized to stay on a subtherapeutic dose because moving up costs more.

PlexusDx sources all tirzepatide compounds from licensed 503A compounding pharmacies, meets rigorous sterility and potency standards, and serves all 50 states without requiring insurance or a membership fee. HSA and FSA accounts can cover your medication. For patients interested in genetic guidance, the Precision Peptide Genetic Test ($99 add-on after your first month) analyzes key variants in your GLP1R, GIPR, FTO, and MC4R genes—genetic markers that influence how your body responds to tirzepatide. This science-backed personalization, combined with transparent pricing, makes finding your optimal dose both safer and more affordable.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of tirzepatide, and can I start higher?

Tirzepatide therapy typically begins at 2.5 milligrams weekly to minimize side effects and allow your body to adapt. Starting higher increases nausea and gastrointestinal upset without improving weight loss outcomes. Your PlexusDx clinician may adjust if you have specific contraindications, but 2.5 mg is the evidence-backed starting point for nearly all patients.

How long do I stay on each dose before moving up?

Most clinicians advance your tirzepatide dose every four weeks if you tolerate it well and have not reached your weight loss goal. The full titration from 2.5 to 15 milligrams typically spans four to five months. Your individual timeline depends on how your body responds and your clinical progress.

Does PlexusDx charge more if I need a higher tirzepatide dose?

No. PlexusDx compounded tirzepatide injection costs $289 per month flat, whether you use 2.5 milligrams or 15 milligrams. Your dose may need to go up. Your price won't. This removes financial barriers to reaching your optimal therapeutic dose.

Is tirzepatide 15 mg safe for long-term use?

Fifteen milligrams is the maximum studied and approved dose for tirzepatide in obesity. It is safe for extended use in eligible patients. However, your clinician may recommend stabilizing at a lower dose—such as 10 or 12.5 milligrams—if you achieve excellent results there with fewer side effects. The best dose is the lowest one that works for you.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes and maps 14 metabolic pathways. This helps your clinician forecast whether you'll likely achieve results at lower or higher doses before you start, enabling smarter, faster titration and better outcomes.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.